{
    "pmcid": "11614295",
    "qa_pairs": {
        "What additional viral proteins were included in the multiantigenic mRNA booster vaccine to enhance immune response breadth?": [
            "Nucleoprotein (N) and membrane (M) proteins",
            "Envelope (E) and nucleocapsid (NC) proteins",
            "Polymerase (P) and accessory (A) proteins",
            "Hemagglutinin (HA) and neuraminidase (NA) proteins"
        ],
        "What is the primary target for neutralizing antibodies in SARS-CoV-2, according to the study?": [
            "The spike protein",
            "The nucleoprotein (N)",
            "The membrane (M) protein",
            "The envelope (E) protein"
        ],
        "What strategy does the study suggest to overcome the challenges posed by spike protein mutations and immune evasion?": [
            "Incorporating additional antigens in vaccine formulations",
            "Focusing solely on the spike protein in vaccines",
            "Developing vaccines targeting only the nucleoprotein",
            "Using inactivated virus vaccines exclusively"
        ],
        "What type of immune responses does the spike protein primarily elicit, which are important for long-term immunity?": [
            "TH1 responses",
            "TH2 responses",
            "Regulatory T cell responses",
            "Cytotoxic T cell responses"
        ],
        "Which SARS-CoV-2 variant showed reduced potency in cross-neutralization by both spike-only and spike-NM boosters?": [
            "Omicron XBB.1.5 subvariant",
            "Delta variant",
            "Alpha variant",
            "Beta variant"
        ]
    }
}